Evan Lippman

Corporate Officer/Principal bei ALNYLAM PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Aktive Positionen von Evan Lippman

Unternehmen	Position	Beginn	Ende
ALNYLAM PHARMACEUTICALS, INC.	Corporate Officer/Principal	21.09.2022	-

Unternehmen	Position	Beginn	Ende
AILERON THERAPEUTICS, INC.	Finanzdirektor/CFO	08.01.2015	31.12.2016
Intima Bioscience, Inc. Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021.	Geschäftsführer	-	-
	Präsident	-	-
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Corporate Officer/Principal	14.06.2012	-

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	2
Undergraduate Degree	2
Masters Business Admin	1

Sektoral

Health Technology	5
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
AILERON THERAPEUTICS, INC.	Health Technology
ALNYLAM PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA.	Health Technology
Intima Bioscience, Inc. Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021.	Health Technology

Private Unternehmen

Health Technology